10x Genomics Total Liabilities 2018-2025 | TXG

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

10x Genomics total liabilities from 2018 to 2025. Total liabilities can be defined as the total value of all possible claims against the corporation.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

10x Genomics total liabilities from 2018 to 2025. Total liabilities can be defined as the total value of all possible claims against the corporation.

Related Stocks
Company Name	Market Cap
Veeva Systems (VEEV)	$47.8B
Hims & Hers Health (HIMS)	$13.1B
Doximity (DOCS)	$11.5B
Tempus AI (TEM)	$10.7B
IRhythm Technologies (IRTC)	$4.4B
Inspire Medical Systems (INSP)	$3.9B
Hinge Health (HNGE)	$3.5B
Privia Health (PRVA)	$2.4B
Schrodinger (SDGR)	$1.6B
Phreesia (PHR)	$1.6B
Azenta (AZTA)	$1.6B
Enovis (ENOV)	$1.6B
Clover Health Investments (CLOV)	$1.5B
Omnicell (OMCL)	$1.4B
Evolent Health (EVH)	$1.1B
Claritev (CTEV)	$664M
Fulgent Genetics (FLGT)	$549M
Standard BioTools (LAB)	$539M
Veradigm (MDRX)	$507M
Butterfly Network (BFLY)	$480M
Talkspace (TALK)	$428M
TruBridge (TBRG)	$347M
Outset Medical (OM)	$320M
Health Catalyst (HCAT)	$285M
Nyxoah SA (NYXH)	$244M
SOPHiA GENETICS SA (SOPH)	$224M
CapsoVision (CV)	$202M
Zepp Health (ZEPP)	$199M
KORU Medical Systems (KRMD)	$157M
American Well (AMWL)	$136M